Safety [R]Evolution

About Safety [R]Evolution

Safety [R]Evolution is a Veeva podcast that brings insights from Safety leaders with diverse backgrounds — life sciences organizations, technology and business consulting, CROs, and more. Discussing the importance of modernizing pharmacovigilance to deliver products quickly and safely to patients, each of our guests is interviewed by David Kološić, Director of Veeva Safety Strategy. Learn how innovation, simplification, and standardization across processes and technology are driving a Safety [R]Evolution.

Publisher

Veeva Systems

Category

science

Language

en

Explicit

No

First episode

28 Aug 2025

Latest episode

10 Nov 2026

Latest episodes

9 episodes in the feed.

1. 

   10 Nov 2026

   Establishing a Scalable Foundation for Patient Safety

   For safety teams at small biotechs, operational efficiency gains have significant impact. Camurus’ Johanna Strandell shares how connecting systems and embracing automation helps her team improve data quality and reduce case processing time by 50 minutes per case. With the right safety foundation, they can scale and increase capacity as a lean team.

2. 

   21 Sept 2026

   Getting Data Right First Time to Optimize Patient Safety

   David Kološić kicks off the new season of Safety [R]Evolution with Ferring’s Janni Hermansen. They discuss why getting data right first time is critical to patient safety, and how advanced automation and AI will simplify and speed up core safety work like case processing.

3. 

   8 Apr 2026

   The Safety Nucleus: From Compliance to Strategic Enabler

   Ipsen’s Pav Rishiraj joins David Kološić to discuss why pharmacovigilance is the nucleus of the industry, and how moving from reactive to predictive safety will improve benefit-risk analysis and establish safety as a strategic enabler for the entire business.

4. 

   3 Mar 2026

   Humanizing PV: Better Patient Experience, Better Safety Data

   In this episode of Safety [R]Evolution, Andrew Rut joins David Kološić to discuss shifting PV from reactive data collection and reporting to a predictive, digital-first model that carefully considers the patient experience, integrates AI and automation, and positions safety as a competitive advantage.

5. 

   2 Feb 2026

   Bringing Safety Operations and Science Together: Big Bang Approach

   UCB’s Adrian Maynier and Veeva’s Mayuran Croos join David Kološić to discuss how to approach a “big bang” consolidation of 17 siloed safety systems into one unified platform for case processing, reporting, signal detection, and content.

6. 

   10 Dec 2025

   Building a Connected Safety Platform for the Future

   David Kološić speaks with Veeva’s Marius Mortensen about the long-term vision for Veeva Safety; the benefits of starting with a trusted, validated cloud platform; and how a platform approach enables connected data and processes, advanced automation, and AI.

7. 

   3 Nov 2025

   Strengthening Safety Oversight for CRO-Sponsor Partnerships

   Biomapas’ Martijn van de Leur and Olga Asimaki join David Kološić to discuss the importance of CRO-sponsor partnerships in pharmacovigilance. They also talk about the need for simplification and standardization, progress on automation and AI, and how QPPV’s are adapting to shifting technology.

8. 

   2 Oct 2025

   Three Pillars of PV Transformation: Technology, Process, and People

   In Episode 2, Eliquent Life Sciences’ Emma-Jane Brookes and Jamie Portnoff speak with David Kološić about simplifying and standardizing PV technology, harmonizing processes across teams and regions, and driving PV transformation through effective change management. Disclaimer: The views expressed are those of the individuals and do not represent Eliquent Life Sciences.

9. 

   28 Aug 2025

   Building the Right Data and Technology Foundation for Safety

   In our launch episode, David Kološić talks with Sandoz’s Aniket Agarwal about how the right data and technology foundation improves speed and operational efficiency for pharmacovigilance teams. We also discuss the benefits and challenges of automation and AI, and where rapidly evolving technologies will take safety in the future. Disclaimer: The views expressed are those of the individual and do not represent Sandoz.